FAVERIN TABLETS 100MG. Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of FAVERIN TABLETS 100MG..

Available Products of FAVERIN TABLETS 100MG.

FAVERIN TABLETS 100MG. 30's

Reg#: 011469

Description of FAVERIN TABLETS 100MG.

Each tablet contains : Fluvoxamine Maleate…….…100.00mg

Medicine Info

Pack Size: 30's

Company: Abbott Laboratories (Pakistan) Limited

Price of FAVERIN TABLETS 100MG.

Price: Rs. 2537.08

Related Keywords

  • FAVERIN TABLETS 100MG. price in Pakistan
  • FAVERIN TABLETS 100MG. tablet price
  • FAVERIN TABLETS 100MG. Capsule price
  • Abbott Laboratories (Pakistan) Limited FAVERIN TABLETS 100MG. price
  • Buy FAVERIN TABLETS 100MG. online
  • FAVERIN TABLETS 100MG. maleate10000mg uses
  • FAVERIN TABLETS 100MG. syrup price
  • FAVERIN TABLETS 100MG. pack 30's cost

FAVERIN TABLETS 100MG. 10's

Reg#: 011469

Description of FAVERIN TABLETS 100MG.

Each tablet contains Fluvoxamine Maleate…….…100.00mg

Medicine Info

Pack Size: 10's

Company: Abbott Laboratories (Pakistan) Limited

Price of FAVERIN TABLETS 100MG.

Price: Rs. 849.35

Related Keywords

  • FAVERIN TABLETS 100MG. price in Pakistan
  • FAVERIN TABLETS 100MG. tablet price
  • FAVERIN TABLETS 100MG. Capsule price
  • Abbott Laboratories (Pakistan) Limited FAVERIN TABLETS 100MG. price
  • Buy FAVERIN TABLETS 100MG. online
  • FAVERIN TABLETS 100MG. maleate10000mg uses
  • FAVERIN TABLETS 100MG. syrup price
  • FAVERIN TABLETS 100MG. pack 10's cost

Alternatives brands of FAVERIN TABLETS 100MG.

Explore alternative brands for FAVERIN TABLETS 100MG. below.

View Alternatives

Explore More Medicines

FEMOSTON 2:10 TABLETS

Abbott Laboratories (Pakistan) Limited

MRP: Rs. 1489.3891

FEMOSTON 1 : 10 TABLETS

Abbott Laboratories (Pakistan) Limited

MRP: Rs. 904.9323

FEMOSTON CONTI TABLETS

Abbott Laboratories (Pakistan) Limited

MRP: Rs. 596.1948

FLEXIN 250MG TABLETS

Abbott Laboratories (Pakistan) Limited

MRP: Rs. 244.0266

FLEXIN 500MG TABLETS

Abbott Laboratories (Pakistan) Limited

MRP: Rs. 437.1377

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!